Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-04-26
2011-04-26
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000
Reexamination Certificate
active
07932227
ABSTRACT:
The present invention relates to methods and compositions useful for the regulation of lacritin, syndecan, and lacritin-syndecan interactions and the signaling pathway downstream of lacritin-syndecan interactions. The invention also relates to regulating lacritin-syndecan interaction to regulate ocular cell survival in response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair.
REFERENCES:
patent: 7320870 (2008-01-01), Laurie
patent: 7459440 (2008-12-01), Laurie
patent: 2002/0102604 (2002-08-01), Milne Edwards
patent: 2002/0164669 (2002-11-01), Ruben
patent: 2007/0167371 (2007-07-01), Laurie
patent: 2007/0167372 (2007-07-01), Laurie
patent: 2007/0207522 (2007-09-01), Laurie
patent: 9827205 (1998-06-01), None
patent: 9835299 (1998-08-01), None
patent: 02065943 (2002-08-01), None
patent: 2004037167 (2004-06-01), None
patent: 2005119899 (2005-12-01), None
Wells, J.A. (1990). Additivity of mutational effects in proteins. Biochemistry. 29(37):8509-8517.
Ngo et al. (1994). Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) The Protein Folding Problem and Tertiary Structure Prediction. Birkhauser:Boston, pp. 491-495.
C. Hirst, et al., “High Levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death”, Molecular and Cellular Biochemistry 246: 111-116, 2003.
M. Beier, et al., “Transforming growth factor beta mediates apoptosis in the ganglion cell layer during all programmed cell death periods of the developing murine retina”, Neuroscience Research 56 (2006), 193-203.
Joo-Young IM, et al., “COX-2 Regulates the insulin-like growth Factor I-induced Potentation of Zn2+—toxicity in Primary Cortical Culture”, Molecular Pharmacology, 66:368-376, 2004.
Zaodung Ling, et al., “Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally”, Experimental Neurology 199 (2006), 499-512.
Erina Kuranaga, et al., “Fas/Fas Ligand System in Prolactin-Induced Apoptosis in Rat Corpus Luteum: Possible Role of Luteal Immune Cells”, Biochemical and Biophysical Research Communications 260, 167-173 (1999).
Emanuela Matteucci, et al., “Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency”, Oncogene (2003) 22, 4062-4073.
Doug Lobner, et al., “Mechanisms of bFGF and NT-4 potentiation of necrotic neuronal death”, Brain Research 954, (2002) 42-50.
Victor T. Solovyan, et al., “Proteolytic Activation of Latent TGF-β Precedes Caspase-3 Activation and Enhances Apoptotic Death of Lung Epithelial Cells”, Journal of Cellular Physiology 207:445-453 (2006).
Vincenzo C. Russo, et al., “Fibroblast Growth Factor-2 Over-Rides Insulin-like Growth Factor-I Induced Proliferation and Cell Survival in Human Neuroblastoma Cells”, Journal of Cellular Physiology 199:371-380 (2004).
Heidi M. Sowter, et al., “Predominant Role of Hypoxia-Inducible Transcription Factor (Hif)-1α versus Hif-2α in Regulation of the Transcriptional Response to Hypoxia1”, Cancer Research 63, 6130-6134, Oct. 1, 2003.
Sandhya Sanghi, et al., “cDNA and Genomic Cloning of Lacritin, a Novel Secretion Enhancing Factor from the Human Lacrimal Gland”, Journal of Molecular Biology, Jun. 2001, vol. 310, No. 29, pp. 127-139.
A.J. Lumdsden, et al., “Paired Oligonucleotide Screening for BM180 in a Human Lacrimal Gland cDNA Library:Clone HL-2,” American Society for Cell Biology Annual Meeting (1998).
Sandhya Sanghi, et al., “cDNA Cloning and Expression of ‘lacritin’, a Novel Secreted Glycoprotein of the Lacrimal Gland”, American Society for Cell Biology Annual Meeting (1999).
Sandhya Sanghi, et al., “Quantitation of Rat Lacrimal Secretion: a Novel Sandwich ELISA with High Sensitivity,” Experimental Eye Research, Academic Press (2000).
Rudinger, J., et al., “Characteristics of the amino acids as components of a peptide hormone sequence”, Peptide Hormones, University Park Press (Baltimore), Jun. 14, 1976.
Bork, Peer; “Powers and Pitfalls in Sequence Analysis” The 70% Hurdle, Genome Research, 2000, 10: 398-400, Cold Spring Harbor Laboratory Press.
Skolnick, et. al., “From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era”, TIBTECH, Jan. 2000, vol. 18: 34-39.
Doerks, et. al., “Protein Annotation: Detective Work for Function Prediction”, Trends in Genetics, Jun. 1998, vol. 14, No. 6: 248-250.
Smith, et. al., “The Challenges of Genome Sequence Annotation or ‘The Devil is in the Details’”, Nature Biotechnology, Nov. 1997, vol. 15: 1222-1223.
Boraschi, et. al., “Interleukin-1 and Interleukin-1 Fragments as Vaccine Adjuvants”, 1999, Methods, 19:108-113.
Prabhakaran, et. al., “Sequencing and Model Structure of a Naja naja atra Protein Fragment”, Journal of Peptide Research, 2000, 56: 12-23.
Fritz, Gerhard, “Molecules in focus—Human APE/Ref-1 Protein”, Int. Journal of Biochemistry, 2000, 32: 925-929.
Ma, et. al', “Heparanase Deglycanation of Syndecan-1 is Required for Binding of the Epithelial-Restricted Prosecretory Mitogen Lacritin”, Journal of Cell Biology, Sep. 25, 2006, vol. 174, No. 7, 1097-1106.
Wang et al., “Restricted Epithelial Proliferation by Lacritin via PKCα-dependent NFAT and mTOR Pathways”, Journal of Cell Biology, Aug. 28, 2006, vol. 174, No. 5, 689-700.
Laurie Gordon W.
Ma Peisong
Lockard Jon M
Saoud Christine J
Sparks Rodney L.
University of Virginia Patent Foundation
LandOfFree
Lacritin-syndecan fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lacritin-syndecan fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lacritin-syndecan fusion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2649007